A meta-analysis which compared the efficacy and safety of P2Y12 inhibitor monotherapy and DAPT in patients with and without DM undergoing PCI showed that this monotherapy did not increase the risk of MACEs in patients with DM [28]. Here, P2RY12 is linked to diabetes mellitus.